Guide to PSA, % Free

WRITTEN BY

The Levels Team

Updated: 05/22/2025|12 min read

Summary

Prostate-specific antigen (PSA) is a protein produced by the prostate gland in men. The % free PSA test measures the ratio of PSA in the blood that isn't bound to protein ("free" PSA) to total PSA and can suggest whether follow-up testing is useful to diagnose a condition.

Why It Matters

PSA is produced in the prostate gland. Its primary function is to liquefy seminal fluid after ejaculation, helping sperm move more freely. In healthy men, very little PSA escapes into the bloodstream.

When prostate cells are damaged or when prostate disease is present, more PSA leaks into the bloodstream, raising blood PSA levels. Elevated levels can be a sign of several conditions, including benign prostatic hyperplasia (BPH), prostatitis (inflammation of the prostate), or prostate cancer.

The percentage of free PSA represents the ratio of free (unbound) PSA to total PSA in the blood. These two forms appear in different proportions depending on the underlying prostate condition.

Having a lower percentage of free PSA may be more likely to suggest prostate cancer. This difference occurs because cancerous prostate cells typically produce more of the bound form of PSA, while benign conditions produce more free PSA.

The % Free PSA test is helpful when total PSA falls in the "diagnostic gray zone" (typically 4-10 ng/mL), where it can be difficult to distinguish between cancer and non-cancerous conditions. In this range, a lower % Free PSA (25% or below) indicates a higher probability of prostate cancer, but additional testing is necessary to diagnose, as prostate testing can have high false positives.

Associated Symptoms 

Percent Free PSA is a lab marker that doesn't cause symptoms on its own, but some symptoms of conditions associated with abnormal % Free PSA may include:

• Difficulty starting or stopping urination
• Weak urine stream
• Increased urinary frequency, especially at night
• Blood in urine or semen
• Pelvic discomfort

Clinical Ranges

Lab Reference Range: >25 % (calc)

Lifestyle Factors That Can Impact It

Activities that can positively impact % Free PSA levels include:

• Regular exercise: Moderate to vigorous physical activity may help maintain healthy PSA levels.
• Healthy diet: Diets high in fruits, vegetables, and plant-based proteins have been associated with lower PSA levels and better prostate health.
• Maintaining weight: Obesity is linked to lower PSA levels due to hemodilution (more blood volume dilutes PSA concentration), but it's associated with a higher risk of aggressive prostate cancer, possibly due to hormonal changes or delayed detection.

Activities that can negatively impact  % Free PSA levels include:

• Smoking: Tobacco use can increase inflammation throughout the body, potentially affecting prostate health and PSA levels.
• Excessive alcohol: Heavy drinking may influence hormone levels and increase inflammation, potentially affecting PSA.

Other Factors That Can Impact It

Genetic Conditions

• Family history of prostate cancer: Men with first-degree relatives (father, brother) who have had prostate cancer have a higher risk of developing it.

Medical Conditions

• Benign prostatic hyperplasia (BPH): This is a non-cancerous enlargement of the prostate, and can raise PSA levels.
• Prostatitis: Inflammation of the prostate can damage the prostate's cells, allowing more PSA to leak into the bloodstream.
• Prostate cancer: Cancerous cells disrupt the normal prostate tissue structure, increasing PSA leakage into the blood.
• Urinary tract infection: Inflammation near the prostate can cause PSA elevation due to inflammation.
• Recent prostate procedures: Any manipulation of the prostate (biopsy, surgery, etc.) can release additional PSA into the bloodstream.

Medications and Supplements

• 5-alpha reductase inhibitors (finasteride, dutasteride): Decrease total PSA by about 50% by reducing prostate volume and inhibiting the conversion of testosterone to dihydrotestosterone, but may not significantly affect the free PSA percentage
• Statins: May reduce PSA levels through anti-inflammatory effects and by lowering cholesterol, which is needed for testosterone production
• Thiazide diuretics: Can potentially lower PSA levels through mechanisms related to fluid balance and hormonal changes
• Nonsteroidal anti-inflammatory drugs (NSAIDs): May decrease PSA levels by reducing inflammation in the prostate, as inflammation can cause PSA leakage into the bloodstream
• Testosterone replacement therapy: Can increase PSA levels by stimulating prostate tissue growth and metabolism, requiring careful monitoring during treatment
• Certain herbal supplements: Some herbal preparations like saw palmetto may affect PSA levels by altering prostate cell activity or through anti-inflammatory properties

Individual Factors

• Age: PSA levels naturally increase with age as the prostate enlarges. This is why age-specific reference ranges are often used when interpreting results.
• Race/ethnicity: African American men tend to have higher baseline PSA levels and higher rates of prostate cancer.
• Prostate volume: Larger prostates naturally produce more PSA, even in the absence of disease.
• Obesity: Fat tissue can influence hormone metabolism, potentially affecting PSA production and prostate health.

Testing Accuracy and Stability

The % Free PSA test improves the specificity of prostate cancer detection when combined with total PSA, particularly in the 4-10 ng/mL range. However, several factors can affect its accuracy.

Factors That Can Affect the Accuracy of Your Test 

• Recent ejaculation (within 48 hours)
• Vigorous exercise, especially cycling, in the 48 hours before testing
• Digital rectal examination within the previous three days
• Recent urinary tract infection or prostatitis
• Prostate procedures (biopsy, surgery) within the previous 1-2 months

How It Relates to Other Markers

Other tests can provide insights about health status when they're viewed alongside % Free PSA results. These tests may include:

• Total PSA: The % Free PSA should always be interpreted in the context of the total PSA value.
• PSA density: This is measured using an ultrasound exam and compares the PSA level to prostate size. Higher density may indicate cancer, as cancerous tissue produces more PSA per volume than benign tissue.
• Prostate Health Index (PHI): Combines total PSA, free PSA, and a precursor form called [-2]proPSA. PHI offers improved cancer detection specificity over % Free PSA alone, particularly for more advanced cancers.
• 4Kscore Test: Incorporates four kallikrein markers (including total and free PSA) with clinical information to predict the risk of aggressive prostate cancer.
• Digital rectal examination (DRE): Physical examination to assess prostate size, consistency, and presence of nodules.
• Prostate MRI: Provides detailed images of the prostate, helping identify suspicious areas for targeted biopsy.

What Results May Mean in the Context of Other Markers

• High PSA + Free PSA %: When total PSA is moderately elevated (4-10 ng/mL), a free PSA percentage equal to or below 25% may suggest a higher likelihood of cancer. Conversely, a free PSA percentage above 25% may suggest BPH is a more likely cause.
• Normal PSA + Low Free PSA %: Warrants follow-up testing or consultation.
• Low % Free PSA + High PSA Density: Can suggest a higher likelihood of cancer. 
• High % Free PSA + Low PSA Density: May suggest benign conditions.
• Low % Free PSA + abnormal DRE Findings: May suggest a higher risk of cancer. Even with a higher % Free PSA, abnormal DRE findings warrant further investigation.

Follow-up Considerations

If the % Free PSA is abnormal, your provider may make some of the following recommendations. You should always speak to your doctor if you have medical questions or before making medical decisions.

When Re-Testing May be Appropriate

Testing protocols and guidance vary; your doctor will help determine the right cadence for you.

• PSA in upper range of normal: Consider repeat testing in 6 months
• Slightly elevated PSA: Repeat test within 1-3 months to confirm
• Post-treatment for prostate cancer: According to oncologist's protocol, typically every 3-6 months initially
• During active surveillance: Every 3-6 months with periodic imaging

Additional Testing Your Doctor May Consider

• Total PSA
• Prostate MRI to visualize prostate anatomy and identify suspicious areas
• PCA3 urine test to measure prostate cancer antigen 3, a genetic marker specific to prostate cancer
• 4Kscore or PHI (Prostate Health Index), an advanced blood test that combines multiple biomarkers
• EXO-DX, a urine-based exosome test that analyzes RNA biomarkers to help distinguish between aggressive and non-aggressive prostate cancer, potentially reducing unnecessary biopsies
• Genetic testing for men with family history of prostate cancer
• Prostate biopsy is the gold standard for diagnosis when PSA and other indicators suggest cancer but is typically done after other tests suggest it is warranted given the risks associated with it, such as infection 

When Additional Care May be Warranted

• High PSA 
• Rapid rise in PSA  
• Any PSA elevation with urinary symptoms 
• Abnormal DRE findings
• Family history of prostate cancer with any PSA elevation 
• Blood in urine or semen

Bibliography